Cargando…
Improvement of Oxidative and Metabolic Parameters by Cellfood Administration in Patients Affected by Neurodegenerative Diseases on Chelation Treatment
Objective. This prospective pilot study aimed at evaluating the effects of therapy with antioxidant compounds (Cellfood, and other antioxidants) on patients affected by neurodegenerative diseases (ND), who displayed toxic metal burden and were subjected to chelation treatment with the chelating agen...
Autores principales: | Fulgenzi, Alessandro, Giuseppe, Rachele De, Bamonti, Fabrizia, Ferrero, Maria Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119708/ https://www.ncbi.nlm.nih.gov/pubmed/25114898 http://dx.doi.org/10.1155/2014/281510 |
Ejemplares similares
-
EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update
por: Fulgenzi, Alessandro, et al.
Publicado: (2020) -
Metabolism modifications and apoptosis induction after Cellfood™ administration to leukemia cell lines
por: Catalani, Simona, et al.
Publicado: (2013) -
EDTA Chelation Therapy for the Treatment of Neurotoxicity
por: Fulgenzi, Alessandro, et al.
Publicado: (2019) -
The effect of CELLFOOD(TM) on radiotherapy or combined chemoradiotherapy: preclinical evidence
por: Nuvoli, Barbara, et al.
Publicado: (2019) -
The usefulness of chelation therapy for the remission of symptoms caused by previous treatment with mercury-containing pharmaceuticals: a case report
por: Corsello, Serafina, et al.
Publicado: (2009)